{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:21:31Z","timestamp":1791685291858,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.amjmed.2005.12.017","type":"journal-article","created":{"date-parts":[[2006,3,25]],"date-time":"2006-03-25T07:16:45Z","timestamp":1143271005000},"page":"S3-S11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":238,"special_numbering":"S1","title":["Preventing Osteoporosis-Related Fractures: An Overview"],"prefix":"10.1016","volume":"119","author":[{"given":"Margery","family":"Gass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bess","family":"Dawson-Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2005.12.017_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2005.12.017_bib2","series-title":"Bone Health and Osteoporosis","year":"2004"},{"key":"10.1016\/j.amjmed.2005.12.017_bib3","unstructured":"National Osteoporosis Foundation. Physician\u2019s Guide to Prevention and Treatment of Osteoporosis. Available at: http:\/\/www.nof.org\/_vti_bin\/shtml.dll\/physguide\/index.htm. Accessed April 27, 2005."},{"key":"10.1016\/j.amjmed.2005.12.017_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1532-5415.2004.52203.x","article-title":"Effect of hip fracture on mortality in elderly women","volume":"52","author":"Empana","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjmed.2005.12.017_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1532-5415.2000.tb02641.x","article-title":"Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass","volume":"48","author":"Ensrud","year":"2000","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjmed.2005.12.017_bib6","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/archinte.159.11.1215","article-title":"Vertebral fractures and mortality in older women","volume":"159","author":"Kado","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2005.12.017_bib7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.7326\/0003-4819-128-10-199805150-00001","article-title":"The association of radiographically detected vertebral fractures with back pain and function","volume":"128","author":"Nevitt","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2005.12.017_bib8","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1359\/jbmr.2003.18.11.1921","article-title":"Estrogen and bone\u2014a reproductive and locomotive perspective","volume":"1","author":"Jarvinen","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.amjmed.2005.12.017_bib9","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(02)08761-5","article-title":"Diagnosis of osteoporosis and assessment of fracture risk","volume":"359","author":"Kanis","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2005.12.017_bib10","unstructured":"World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneva, Switzerland: World Health Organization, 1994. WHO Technical Report Series 843."},{"key":"10.1016\/j.amjmed.2005.12.017_bib11","first-page":"84","article-title":"Management of postmenopausal osteoporosis position statement of the North American Menopause Society","volume":"9","year":"2002","journal-title":"Menopause"},{"key":"10.1016\/j.amjmed.2005.12.017_bib12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.4158\/EP.9.6.544","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis","volume":"9","author":"Hodgson","year":"2003","journal-title":"Endocr Pract"},{"key":"10.1016\/j.amjmed.2005.12.017_bib13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00198-003-1436-x","article-title":"Effects of exercise on bone mineral density in calcium-replete postmenopausal women with and without hormone replacement therapy","volume":"14","author":"Going","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.amjmed.2005.12.017_bib14","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1001\/jama.1990.03440220053029","article-title":"High-intensity strength training in nonagenarians","volume":"263","author":"Fiatarone","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2005.12.017_bib15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1056\/NEJM199709043371003","article-title":"Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older","volume":"337","author":"Dawson-Hughes","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2005.12.017_bib16","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM199009273231305","article-title":"A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women","volume":"323","author":"Dawson-Hughes","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2005.12.017_bib17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9343(99)80310-6","article-title":"Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women","volume":"98","author":"Reid","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2005.12.017_bib18","unstructured":"National Institutes of Health, Office of Dietary Supplements. Dietary Supplement Fact Sheet. Available at: http:\/\/ods.od.nih.gov\/factsheets\/calcium.asp. Accessed March 1, 2006."},{"key":"10.1016\/j.amjmed.2005.12.017_bib19","unstructured":"National Institutes of Health, Office of Dietary Supplements. Dietary Supplement Fact Sheet: Vitamin D. Available at: http:\/\/ods.od.nih.gov\/factsheets\/vitamind.asp. Accessed March 1, 2006."},{"key":"10.1016\/j.amjmed.2005.12.017_bib20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/oxfordjournals.aje.a116681","article-title":"Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly","volume":"137","author":"O\u2019Loughlin","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.amjmed.2005.12.017_bib21","unstructured":"National Osteoporosis Foundation. Patient Info: Fall Prevention. Available at http:\/\/www.nof.org\/patientinfo\/fall_prevention.htm. Accessed April 27, 2005."},{"key":"10.1016\/j.amjmed.2005.12.017_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001255.pub2","article-title":"Hip protectors for preventing hip fractures in the elderly","volume":"3","author":"Parker","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"pt 1","key":"10.1016\/j.amjmed.2005.12.017_bib23","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/000348949009900914","article-title":"Inhibition of osteoclast recruitment at a local site by 1-hydroxyethylidene-1,1-bisphosphonate (HEBP)","volume":"99","author":"Adachi","year":"1990","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.amjmed.2005.12.017_bib24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI114459","article-title":"Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro","volume":"85","author":"Carano","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjmed.2005.12.017_bib25","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","article-title":"Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo","volume":"10","author":"Hughes","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.amjmed.2005.12.017_bib26","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2005.12.017_bib27","series-title":"Fosamax (alendronate sodium) tablet and oral solution [prescribing information]","year":"2004"},{"key":"10.1016\/j.amjmed.2005.12.017_bib28","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2005.12.017_bib29","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2005.12.017_bib30","series-title":"Actonel (risedronate sodium tablets) [prescribing information]","year":"2004"},{"key":"10.1016\/j.amjmed.2005.12.017_bib31","series-title":"Boniva (ibandronate sodium) tablets [prescribing information]","year":"2005"},{"key":"10.1016\/j.amjmed.2005.12.017_bib32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.amjmed.2005.12.017_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1385\/JCD:6:1:45","article-title":"Bone density changes with once weekly risedronate in postmenopausal women","volume":"6","author":"Delaney","year":"2003","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.amjmed.2005.12.017_bib34","first-page":"6","article-title":"Alendronate and risedronate for the treatment of postmenopausal osteoporosis","volume":"6","author":"Emkey","year":"2004","journal-title":"MedGenMed"},{"key":"10.1016\/j.amjmed.2005.12.017_bib35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4158\/EP.8.3.202","article-title":"Response of bone mineral density to once-weekly administration of risedronate","volume":"8","author":"Gordon","year":"2002","journal-title":"Endocr Pract"},{"key":"10.1016\/j.amjmed.2005.12.017_bib36","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1359\/jbmr.2002.17.11.1988","article-title":"Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis","volume":"17","author":"Rizzoli","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2005.12.017_bib37","first-page":"S448","article-title":"Does dosing regimen impact persistence with bisphosphonate therapy among postmenopausal osteoporotic women?","volume":"19","author":"Cramer","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.amjmed.2005.12.017_bib38","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(02)08827-X","article-title":"Treatment of postmenopausal osteoporosis","volume":"359","author":"Delmas","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2005.12.017_bib39","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2005.12.017_bib40","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in postmenopausal women","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2005.12.017_bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1006478317173","article-title":"Continued breast cancer risk reduction in postmenopausal women treated with raloxifene","volume":"65","author":"Cauley","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.amjmed.2005.12.017_bib42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2005.12.017_bib43","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2005.12.017_bib44","unstructured":"Forteo (teriparatide rDNA origin) injection 750 \u03bcg\/3 mL [prescribing information]. Indianapolis, IN: Eli Lilly and Company; 2004."},{"key":"10.1016\/j.amjmed.2005.12.017_bib45","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2005.12.017_bib46","unstructured":"Miacalcin (calcitonin-salmon) nasal spray [prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals Corp.; 2003."},{"key":"10.1016\/j.amjmed.2005.12.017_bib47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9343(00)00490-3","article-title":"A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis","volume":"109","author":"Chesnut","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2005.12.017_bib48","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1210\/er.2001-6002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934305011976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934305011976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:41:52Z","timestamp":1757580112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934305011976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0002934305011976"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2005.12.017","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventing Osteoporosis-Related Fractures: An Overview","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2005.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}